Showing results (11-20 of 20) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 20 results.
ACS Central Science|July 8, 2021
Inhibiting Ferroptosis through Disrupting the NCOA4-FTH1 Interaction: A New Mechanism of ActionYuying Fang, Xiucai Chen, Qingyun Tan, et al.
Bioorganic Chemistry|March 9, 2024
Identifying eleven new ferroptosis inhibitors as neuroprotective agents from FDA-approved drugsQingyun Tan, Deyin Wu, Yating Lin, et al.
Journal of Natural Products|August 11, 2023
Discovery of neo-Clerodane Diterpenoids from Ajuga campylantha as Neuroprotective Agents against Ferroptosis and NeuroinflammationXing Peng, Qingyun Tan, Zhikang Zhang, et al.
Molecular Medicine Reports|July 7, 2022
ANP32E contributes to gastric cancer progression via NUF2 upregulationXiaowen Zhu, Yumin Zou, Tong Wu, et al.
European Journal of Medicinal Chemistry|April 20, 2025
Development of potent inhibitors targeting bacterial prolyl-tRNA synthetase through fluorine scanning-directed activity tuningZhiteng Luo, Haipeng Qiu, Xiaoying Peng, et al.
Journal of Agricultural and Food Chemistry|November 27, 2018
Structure-Activity Relationship Analysis on Antioxidant and Anticancer Actions of Theaflavins on Human Colon Cancer CellsQingyun Tan, Lijiao Peng, Yanyu Huang, et al.
Fitoterapia|February 22, 2023
Chemical constituents of Ajuga forrestii and their anti-ferroptosis activityHuiwen Shi, Xiufen Jiang, Liudan Cao, et al.
Cardiovascular Toxicology|May 22, 2021
Indoleamine 2,3-Dioxygenase 1 (IDO1) Promotes Cardiac Hypertrophy via a PI3K-AKT-mTOR-Dependent MechanismYang Liu, Shuang Li, Zhanqun Gao, et al.
European Journal of Medicinal Chemistry|January 23, 2021
Synthesis and evaluation of andrographolide derivatives as potent anti-osteoporosis agents in vitro and in vivoSongxuan Zhang, Yuting Zhang, Yuying Fang, et al.
Pageof 2